Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 100(21): 12480-5, 2003 Oct 14.
Article in English | MEDLINE | ID: mdl-14523239

ABSTRACT

Protein kinase C (PKC) modulates the function of the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). This modulation manifests as increased current when the channel is activated by capsaicin. In addition, studies have suggested that phosphorylation by PKC might directly gate the channel, because PKC-activating phorbol esters induce TRPV1 currents in the absence of applied ligands. To test whether PKC both modulates and gates the TRPV1 function by direct phosphorylation, we used direct sequencing to determine the major sites of PKC phosphorylation on TRPV1 intracellular domains. We then tested the ability of the PKC-activating phorbol 12-myristate 13-acetate (PMA) to potentiate capsaicin-induced currents and to directly gate TRPV1. We found that mutation of S800 to alanine significantly reduced the PMA-induced enhancement of capsaicin-evoked currents and the direct activation of TRPV1 by PMA. Mutation of S502 to alanine reduced PMA enhancement of capsaicin-evoked currents, but had no effect on direct activation of TRPV1 by PMA. Conversely, mutation of T704 to alanine had no effect on PMA enhancement of capsaicin-evoked currents but dramatically reduced direct activation of TRPV1 by PMA. These results, combined with pharmacological studies showing that inactive phorbol esters also weakly activate TRPV1, suggest that PKC-mediated phosphorylation modulates TRPV1 but does not directly gate the channel. Rather, currents induced by phorbol esters result from the combination of a weak direct ligand-like activation of TRPV1 and the phosphorylation-induced enhancement of the TRPV1 function. Furthermore, modulation of the TRPV1 function by PKC appears to involve distinct phosphorylation sites depending on the mechanism of channel activation.


Subject(s)
Protein Kinase C/metabolism , Receptors, Drug/metabolism , Animals , COS Cells , Enzyme Activation/drug effects , In Vitro Techniques , Ion Channel Gating , Kinetics , Phosphorylation , Receptors, Drug/chemistry , Receptors, Drug/genetics , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Transfection
2.
J Neurophysiol ; 90(3): 1671-9, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12750419

ABSTRACT

The transient outward potassium currents (also known as A-type currents or IA) are important determinants of neuronal excitability. In the brain, IA is modulated by protein kinase C (PKC), protein kinase A (PKA), and extracellular signal-related kinase (ERK), three kinases that have been shown to be critical modulators of nociception. We wanted to determine the effects of these kinases on IA in superficial dorsal horn neurons. Using whole cell recordings from cultured mouse spinal cord superficial dorsal horn neurons, we found that PKC and PKA both inhibit IA in these cells, and that PKC has a tonic inhibitory action on IA. Further, we provide evidence supporting the hypothesis that PKC and PKA do not modulate IA directly, but rather act as upstream activators of ERKs, which modulate IA. These results suggest that ERKs serve as signal integrators in modulation of IA in dorsal horn neurons and that modulation of A-type potassium currents may underlie aspects of central sensitization mediated by PKC, PKA, and ERKs.


Subject(s)
Cyclic AMP-Dependent Protein Kinases/metabolism , Mitogen-Activated Protein Kinases/metabolism , Posterior Horn Cells/enzymology , Potassium Channels/physiology , Protein Kinase C/metabolism , Animals , Cells, Cultured , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/physiology , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mice, Inbred ICR , Mitogen-Activated Protein Kinases/antagonists & inhibitors , Posterior Horn Cells/drug effects , Potassium Channels/classification , Protein Kinase C/antagonists & inhibitors
3.
J Biol Chem ; 278(32): 30294-301, 2003 Aug 08.
Article in English | MEDLINE | ID: mdl-12764131

ABSTRACT

The metabotropic glutamate receptors (mGluRs) have been predicted to have a classical seven transmembrane domain structure similar to that seen for members of the G-protein-coupled receptor (GPCR) superfamily. However, the mGluRs (and other members of the family C GPCRs) show no sequence homology to the rhodopsin-like GPCRs, for which this seven transmembrane domain structure has been experimentally confirmed. Furthermore, several transmembrane domain prediction algorithms suggest that the mGluRs have a topology that is distinct from these receptors. In the present study, we set out to test whether mGluR5 has seven true transmembrane domains. Using a variety of approaches in both prokaryotic and eukaryotic systems, our data provide strong support for the proposed seven transmembrane domain model of mGluR5. We propose that this membrane topology can be extended to all members of the family C GPCRs.


Subject(s)
Receptors, Metabotropic Glutamate/chemistry , Algorithms , Ampicillin/pharmacology , Animals , COS Cells , Cattle , Cell Membrane/metabolism , Cloning, Molecular , Drug Resistance, Bacterial , Epitopes , Escherichia coli/metabolism , Gene Deletion , Glycosylation , Microscopy, Fluorescence , Models, Biological , Peptides/chemistry , Protein Structure, Tertiary , Receptor, Metabotropic Glutamate 5 , Receptors, Metabotropic Glutamate/metabolism , Recombinant Fusion Proteins/metabolism , Recombinant Proteins/chemistry , Transfection , beta-Lactamases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL